Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 7510-7518

  Vassiliadou, Neratzoula ^a   Tucker, Lynne ^a   Anderson, Deborah J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1; PROGESTERONE;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MONONUCLEAR CELL; MUCOSAL IMMUNITY; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEXUAL TRANSMISSION; STROMA CELL; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS TRANSMISSION;

EID: 0033564346     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.162.12.7510     Document Type: Article

References (58)

1. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
2. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
3. + cells. Science 270:1811.
4. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skurnick, N. L. Van Devanter, N. Padian, J. F. Braun, D. P. Kodler, S. M. Wolinsky, et al. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412.
5. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667.
6. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion co-factor for macrophage-tropic HIV-1. Science 272:1955.
7. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872.
8. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
9. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 85:1149.
10. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661.
11. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367.
12. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722.
13. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vitinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856.
14. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, et al. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240.
15. Rottman, J. B., K. P. Ganley, K. Williams, L. Wu, C. R. Mackay, and D. J. Ringler. 1997. Cellular localization of the chemokine receptor CCR5: correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151:1341.
16. Anderson, D. J., R. Fichorova, F. Haimovici, Y. M. Wang, and J. Pudney. 1997. β-Chemokines and their receptors in the lower female genital tract. J. Soc. Gynecol. Invest. 4:201A.
17. Patterson, B. K., A. Landay, J. Anderson, C. Brown, H. Behbahani, D. Jiyamapa, Z. Burki, D. Stanislawski, M. A. Czerniewski, and P. Garcia. 1998. Repertoire of chemokine receptor expression in the female genital tract. Am. J. Pathol. 153: 481.
18. Grossman, C. J. 1984. Regulation of the immune system by sex steroids. Endocr. Rev. 5:435.
19. Schuurs, A. H. W. M., T. B. P. Geurt, E. M. Goorissen, J. M. W. Hazes, and H. A. M. Verheul. 1994. Immunologic effects of estrogens, progestins, and estrogen-progestin combinations. In Pharmacology of the Contraceptive Steroids. J. Goldzieher, ed. Raven Press, New York, p. 379.
20. Paavonen, T. 1994. Hormonal regulation of immune response. Ann. Med. 26:255.
21. DaSilva, J. A. 1995. Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Ann. Rheum. Dis. 54:6.
22. Whitelaw, P. F., and B. A. Croy. 1996. Granulated lymphocytes of pregnancy. Placenta 17:533.
23. + lymphocytes in an in vitro culture system. J. Clin. Endocrinol. Metab. 81:1502.
24. Clemens, L. E., P. K. Siiteri, and D. P. Stites. 1979. Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. J. Immunol. 122:1978.
25. Mannel, D. N., W. Falk, and I. Yron. 1990. Inhibition of murine cytotoxic T cell responses by progesterone. Immunol. Lett. 26:89.
26. Piccinni, M. P., M. G. Giudizi, R. Biagiotti, L. Beloni, L. Giannarini, S. Sampognaro, P. Parronchi, R. Manetti, F. Annunziato, C. Livi, et al. 1995. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. 155:128.
27. + CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J. Immunol. 158:3017.
28. Feinberg, B. B., D. J. Anderson, M. A. Steller, V. Fulop, R. S. Berkowitz, and J. A. Hill. 1994 Cytokine regulation of trophoblast steroidogenesis. J. Clin. Endocrinol. Metab. 78:586.
29. Pedersen, A. M., B. K. Taylor, A. M. Payne, M. Abdelrahim, and G. L. Francis. 1994. Macrophage conditioned media affects steroid hormone production by placental cultures. Ann. Clin. Lab. Sci. 24:548.
30. Best, C. L., P. M. Griffin, and J. A. Hill. 1995. Interferon γ inhibits luteinized human granulosa cell steroid production in vitro. Am. J. Obstet. Gynecol. 172: 1505.
31. Stimson, W. H. 1988. Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand. J. Immunol. 28:345.
32. Schust, D. J., D. J. Anderson, and J. A. Hill. 1996. Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum. Reprod. 11:980.
33. King, A., L. Gardner, and Y. M. Loke. 1996. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum. Reprod. 11:1079.
34. Svec, F., V. Teubner, and D. Tate. 1989. Location of the second steroid-binding site on the glucocorticoid receptor. Endocrinology 125:3103.
35. Baker, D. A., C. A. Phillips, K. Roessner, R. J. Albertini, and L. I. Mann. 1980. Suppression by progesterone of nonspecific in vitro lymphocyte stimulation in mice as a mechanism for the enhancement of herpes simplex virus type 2 vaginal infection. Am. J. Obstet. Gynecol. 136:440.
36. Furr, P. M., and D. Taylor-Robinson. 1993. The contrasting effects of progesterone and estrogen on the susceptibility of mice to genital tract infection with Mycoplasma pulmonis. J. Med. Microbiol. 38:160.
37. Kaushic, C., A. D. Merdin, B. J. Underdown, and C. R. Wira. 1998. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect. Immun. 66:893.
38. Marx, P. A., A. I. Spira, A. Gettie, P. J. Dailey, R. S. Veazey, A. A. Lackner, C. J. Mahoney, C. J. Miller, L. E. Claypool, D. D. Ho, et al. 1996. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2:1084.
39. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, et al. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. J. Exp. Med. 185:1681.
40. Goebelsmann, U. 1986. Steroid hormones. In Infertility, Contraception and Reproductive Endocrinology. D. R. Mishell, Jr., and V. Danajan, eds. Medical Economics Books, Oradell, NJ, p. 45.
41. Goebelsmann, U. 1986. Steroid hormones. In Infertility, Contraception and Reproductive Endocrinology. D. R. Mishell, Jr., and V. Danajan, eds. Medical Economics Books, Oradell, NJ, p. 113.
42. Runnebaum, B., I. Stober, and J. Zander. 1975. Progesterone, 20α-dihydroprogesterone and 20β-dihydroprogesterone in mother and child at birth. Acta Endocrinol. (Copenh.) 80:569.
43. Endres, M. J., P. R. Clapham, M. Marsh, M. Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, et al. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745.
44. Amara, A., S. L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J.-L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139.
45. Gallo, R. C., S. Z. Salahuddink, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redclief, J. Oleske, B. Safai, et al. 1984. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500.
46. Shaw, G. M., B. H. Hahn, S. K. Arya, J. E. Groopman, R. C. Gallo, and F. Wong-Staal. 1984 Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226:1165.
47. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vinters, and I. S. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819.
48. Cann, A. J., J. A. Zack, A. S. Go, S. J. Arrigo, Y. Koyanagi, P. L. Green, Y. Koyanagi, S. Pang, and I. S. Chen. 1990. Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J. Virol. 64:4735.
49. Gosh, D. 1992. Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat. J. Virol. 66:586.
50. Miksicek, R., A. Heber, W. Schmid, U. Danesch, G. Posseckert, M. Beato, and G. Schutz. 1986. Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell 46:283.
51. Bourinbaiar, A. S., R. Nagorny, and X. Tan. 1992. Pregnancy hormones, estrogen and progesterone, prevent HIV-1 synthesis in monocytes but not in lymphocytes. FEBS Lett. 302:206.
52. Lee, A. W., D. Mitra, and J. Lawrence. 1997. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type I replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV. AIDS Res. Hum. Retroviruses 13:1235.
53. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The chemokine receptors CXCR4 and CCR5 are differentially expressed and regulated on T cells. Proc. Natl. Acad. Sci. USA 94:1925.
54. Ward, S. G., and J. Westwick. 1998. Chemokines: understanding their role in T lymphocyte biology. Biochem. J. 333:457.
55. Furie, M. B., and G. J. Randolph. 1995. Chemokines and tissue injury. Am. J. Pathol. 146:1287.
56. Roncalli, M., M. Sideri, P. Gie, and E. Servida. 1988. Immunophenotypic analysis of the transformation zone of the human cervix. Lab. Invest. 58:141.
57. Parr, M. B., and E. L. Parr. 1997. Protective immunity against HSV-2 in the mouse vagina. J. Reprod. Immunol. 36:77.
58. Cates, W. 1997. Hormonal contraception and STD/HIV: what do we know? (Abstract) In Abstracts from the National Conference on Women and HIV. p. 108.